| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-16 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-15 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.26 | 5e-15 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.26 | 6e-15 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.26 | 6e-14 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.23 | 9e-14 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.27 | 1e-13 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-13 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-13 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-13 |